Variant report
Variant | rs10978775 |
---|---|
Chromosome Location | chr9:110021726-110021727 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:110015966..110018595-chr9:110020108..110022273,3 | MCF-7 | breast: | |
2 | chr9:110021248..110023658-chr9:110046181..110048340,2 | K562 | blood: | |
3 | chr9:110021549..110024530-chr9:110031690..110034147,2 | MCF-7 | breast: | |
4 | chr9:110007992..110013194-chr9:110021107..110025881,5 | MCF-7 | breast: | |
5 | chr9:110021032..110023010-chr9:110046369..110047881,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000119318 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10113916 | 0.86[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs10119641 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.99[ASN][1000 genomes] |
rs10122970 | 1.00[ASN][1000 genomes] |
rs10481632 | 1.00[CHB][hapmap];0.88[JPT][hapmap];0.84[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10521083 | 0.84[CHB][hapmap] |
rs10732368 | 0.84[CHB][hapmap] |
rs10739232 | 0.88[CHB][hapmap] |
rs10739234 | 0.84[CHB][hapmap] |
rs10739236 | 0.85[CEU][hapmap];0.89[CHB][hapmap];0.83[JPT][hapmap];0.90[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10739238 | 0.84[CHB][hapmap] |
rs10759219 | 0.89[CHB][hapmap] |
rs10759222 | 0.84[CHB][hapmap] |
rs10816473 | 0.80[AMR][1000 genomes] |
rs10816474 | 0.93[AMR][1000 genomes] |
rs10816477 | 0.93[CEU][hapmap];1.00[CHB][hapmap];0.94[JPT][hapmap];0.96[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs10816480 | 1.00[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs10816485 | 1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10816490 | 0.88[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs10816491 | 0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs10978767 | 0.94[CHB][hapmap];0.94[JPT][hapmap];0.93[AMR][1000 genomes] |
rs10978769 | 0.89[CHB][hapmap];0.94[JPT][hapmap] |
rs10978770 | 0.89[CHB][hapmap] |
rs10978776 | 1.00[ASN][1000 genomes] |
rs10978777 | 1.00[ASN][1000 genomes] |
rs10978791 | 1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs12342066 | 0.97[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs12345455 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes] |
rs12555417 | 1.00[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1323808 | 0.84[CHB][hapmap] |
rs1519049 | 0.82[AMR][1000 genomes] |
rs1519050 | 0.85[AMR][1000 genomes] |
rs1535765 | 0.84[CHB][hapmap] |
rs1535766 | 0.89[CHB][hapmap] |
rs1805329 | 0.86[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs1805332 | 0.84[CHB][hapmap] |
rs1805334 | 0.84[CHB][hapmap] |
rs1886134 | 0.84[CHB][hapmap] |
rs2005143 | 0.95[ASN][1000 genomes] |
rs2147072 | 0.84[CHB][hapmap] |
rs2417776 | 1.00[ASN][1000 genomes] |
rs2417784 | 0.85[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs2417785 | 0.84[CHB][hapmap] |
rs2808362 | 0.85[AMR][1000 genomes] |
rs2808363 | 0.85[AMR][1000 genomes] |
rs2808365 | 0.85[AMR][1000 genomes] |
rs28534368 | 0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs28769087 | 1.00[AFR][1000 genomes];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs28848858 | 0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4278207 | 0.84[CHB][hapmap] |
rs4481670 | 0.83[CHB][hapmap] |
rs4978849 | 0.83[CHB][hapmap] |
rs61701375 | 0.86[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs698475 | 0.85[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7029997 | 0.84[CHB][hapmap] |
rs7030169 | 0.84[CHB][hapmap] |
rs7031906 | 0.84[CHB][hapmap] |
rs7035611 | 0.84[CHB][hapmap] |
rs7036284 | 1.00[ASN][1000 genomes] |
rs7038737 | 0.83[CHB][hapmap] |
rs7040217 | 0.92[ASN][1000 genomes] |
rs7041137 | 1.00[CHB][hapmap];0.94[JPT][hapmap];0.92[ASN][1000 genomes] |
rs7041497 | 0.84[CHB][hapmap] |
rs7046950 | 0.84[CHB][hapmap] |
rs7852295 | 0.89[CHB][hapmap] |
rs7861304 | 0.85[AMR][1000 genomes] |
rs7866312 | 0.89[CHB][hapmap] |
rs7866353 | 0.89[CHB][hapmap] |
rs7866797 | 0.89[CHB][hapmap] |
rs7867544 | 0.94[CHB][hapmap];0.94[JPT][hapmap];0.93[AMR][1000 genomes];0.87[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs7873745 | 0.99[ASN][1000 genomes] |
rs817836 | 0.85[CEU][hapmap];1.00[CHB][hapmap];0.89[JPT][hapmap];0.86[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs817838 | 0.87[ASN][1000 genomes] |
rs817839 | 0.87[ASN][1000 genomes] |
rs817840 | 1.00[CHB][hapmap];0.89[JPT][hapmap];0.87[ASN][1000 genomes] |
rs817841 | 1.00[CHB][hapmap];0.89[JPT][hapmap];0.87[ASN][1000 genomes] |
rs817843 | 0.87[ASN][1000 genomes] |
rs817844 | 0.87[ASN][1000 genomes] |
rs817845 | 0.87[ASN][1000 genomes] |
rs817847 | 0.81[ASN][1000 genomes] |
rs942291 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes] |
rs942293 | 0.84[CHB][hapmap] |
rs9632893 | 0.94[CHB][hapmap];0.86[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs9969728 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv869351 | chr9:109593212-110191170 | Active TSS Genic enhancers Weak transcription Strong transcription Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
2 | nsv530948 | chr9:109760752-110413602 | Weak transcription Flanking Active TSS Enhancers Active TSS Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 57 gene(s) | inside rSNPs | diseases |
3 | nsv831682 | chr9:109937181-110075453 | Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
4 | nsv893698 | chr9:109998563-110052660 | Enhancers Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
5 | nsv508560 | chr9:110006490-110060539 | Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
6 | esv3508199 | chr9:110017856-110022181 | Enhancers Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | inside rSNPs | n/a |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:110007000-110022600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr9:110012400-110022600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr9:110014800-110022800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr9:110015400-110022600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr9:110017200-110022600 | Weak transcription | HSMMtube | muscle |
6 | chr9:110018200-110022400 | Weak transcription | HepG2 | liver |
7 | chr9:110020800-110022600 | Weak transcription | NHDF-Ad | bronchial |
8 | chr9:110021000-110023800 | Enhancers | Liver | Liver |
9 | chr9:110021400-110022600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr9:110021400-110024000 | Enhancers | Primary B cells from peripheral blood | blood |
11 | chr9:110021600-110022600 | Weak transcription | Adipose Nuclei | Adipose |